Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.6.393

Formulation and Evaluation of Moisture-activated Acyclovir Patches  

Kim, Ah-Mee (College of Pharmacy, Dongduk Women's University)
Gwak, Hye-Sun (College of Pharmacy, Ewha Womans University)
Chun, In-Koo (College of Pharmacy, Dongduk Women's University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.6, 2006 , pp. 393-399 More about this Journal
Abstract
This study was aimed to design, formulate and characterize the moisture-activated patches containing acyclovir for antiviral action. Gel intermediates for film-type patches were prepared with mucoadhesive polymer, viscosity builders, enhancers and acyclovir. Patches containing acyclovir were characterized by in vitro measurement of drug release rates through a cellulose barrier membrane, and of drug flux through the hairless mouse skin. Film-type patches obtained were uniform in the thickness and showed a mucoadhesive property when contacted with moisture. The formulation was optimized, which consisted of $Cantrez^{\circledR}$ AN-169(2%), $Kollidon^{\circledR}$ VA 64(1%), $Natrosol^{\circledR}$(1%), hydroxypropyl-$\beta$-cyclodextrin(1%) and dimethylsulfoxide(0.5%). Release rates of acyclovir patches increased dose-dependently. The addition of terpenes such as d-limonene or cineole increased release rates of acyclovir, but decreased permeation rates. The permeation rates were enhanced by 2 and 2.5 times by the addition of glycyrrhizic acid ammonium salt and sodium glycocholate, respectively, compared with that of no enhancer. These results suggest that it may be feasible to deliver acyclovir through the skin or gingival mucosa from the moisture-activated patches.
Keywords
Acyclovir; Moisture-activated patches; Release rates; Permeation rates;
Citations & Related Records
연도 인용수 순위
  • Reference
1 D.F. McCafferty, A.D. Woolfson and G.P. Moss, Novel bioadhesive delivery system for percutaneous local anaesthesia, Br. J. Anaesth., 84, 456-458 (2000)   DOI   ScienceOn
2 E. Sozen, A.M. Avunduk and N. Akyol, Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial, Chemotherapy, 52, 29-31 (2006)   DOI   ScienceOn
3 S.A. Qureshi, M. Jiang, K.K. Midha and J.P. Skelly, In vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin, J. Pharm. Pharm. Sci., 1, 102-107 (1998)
4 G.R. Kinghorn, Topical acyclovir in the treatment of recurrent herpes simplex virus infections, Scand. J. Infect. Dis. Suppl., 47, 58-62 (1985)
5 T. Nagai, Topical mucosal adhesive dosage forms, Med. Res. Rev., 6, 227-242 (1986)   DOI   ScienceOn
6 Y.W. Chien and H.J. Lambert, Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanism, J. Pharm. Sci., 63, 515-519 (1974)   DOI
7 A.D. Woolfson, D.F. McCafferty and V. Boston, Clinical experiences with a novel percutaneous amethocaine prepara- tion: prevention of pain due to venepuncture in children, Br. J. Clin. Pharmacol., 30, 273-279 (1990)   DOI   ScienceOn
8 D.F. McCafferty and A.D. Woolfson, New patch delivery system for percutaneous local anaesthesia, Br. J. Anaesth., 71, 370-374 (1993)   DOI   ScienceOn
9 M. Ishida, N. Nambu, and T. Nagai, Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and Carbopol, Chem. Pharm. Bull., 30, 980-984 (1982)   DOI   ScienceOn
10 A.D. Woolfson, D.F. McCafferty and G.P. Moss, Develop- ment and characterization of a moisture-activated bioad- hesive drug delivery system for percutaneous local anaes- thesia, Int. J. Pharm., 169, 83-94 (1998)   DOI   ScienceOn
11 M. Ishida, Y. Machida, N. Nambu and T. Nagai, New mucosal dosage form of insulin, Chem. Pharm. Bull., 29, 810-816 (1981)   DOI   ScienceOn
12 A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17-24 (1991)   DOI
13 J. Neyts, G. Andrei and E. De Clercq, The novel immuno- suppressive agent mycophenolate mofetil markedly poten- tiates the antiherpesvirus activities of acyclovir, gancyclovir, and penciclovir in vitro and in vivo, Antimicrob. Agents Chemother., 181, 216-222 (1998)
14 F.G. Hayden, Antimicrobial Agents: In The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird and A.G. Gilman (Ed.), McGraw-Hill, New York, USA, pp. 1317-1322 (2001)